These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6152699)

  • 1. Progress report from the Division of Behavioral Biology, the Johns Hopkins University School of Medicine.
    Bigelow GE; Brady JV; Griffiths RR; Stitzer ML; Ator NA; Higgins ST; Liebson IA; Lucas SE
    NIDA Res Monogr; 1984; 55():66-75. PubMed ID: 6152699
    [No Abstract]   [Full Text] [Related]  

  • 2. The new mixed agonist-antagonist analgesics, nalbuphine and butorphanol, vs. pentazocine: relapse and substitution in morphine-addict rats.
    Steinfels GF; Young GA; Khazan N
    NIDA Res Monogr; 1981 Feb; 34():138-44. PubMed ID: 6783923
    [No Abstract]   [Full Text] [Related]  

  • 3. Self-administration of nalbuphine, butorphanol and pentazocine by morphine post-addict rats.
    Steinfels GF; Young GA; Khazan N
    Pharmacol Biochem Behav; 1982 Jan; 16(1):167-71. PubMed ID: 7199184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substitution and primary dependence studies in animals.
    Woods JH; Gmerek DE
    Drug Alcohol Depend; 1985 Feb; 14(3-4):233-47. PubMed ID: 4039649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline.
    Walker EA; Picker MJ; Granger A; Dykstra LA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):150-8. PubMed ID: 15044559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
    Jones HE; Bigelow GE; Preston KL
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing drugs for abuse liability and behavioral toxicity: progress report from the laboratories at the Johns Hopkins University School of Medicine.
    Brady JV; Griffiths RR
    NIDA Res Monogr; 1983 Apr; 43():99-124. PubMed ID: 6135997
    [No Abstract]   [Full Text] [Related]  

  • 8. Narcotic discrimination in pigeons.
    Herling S; Coale EH; Valentino RJ; Hein DW; Woods JH
    J Pharmacol Exp Ther; 1980 Jul; 214(1):139-46. PubMed ID: 6993656
    [No Abstract]   [Full Text] [Related]  

  • 9. Abuse liability and behavioral toxicity assessment: progress report from the behavioral biology laboratories of the Johns Hopkins University School of Medicine.
    Brady JV; Griffiths RR; Hienz RD; Bigelow GE; Emurian HH; Lukas SE; Ator NA; Nellis MJ; Ray RL; Pearlson GD
    NIDA Res Monogr; 1984 Mar; 49():92-108. PubMed ID: 6148698
    [No Abstract]   [Full Text] [Related]  

  • 10. Nalbuphine, pentazocine, and butorphanol interactions with tripelennamine in mice.
    Schmidt WK; Marynowski ME; Smith C
    NIDA Res Monogr; 1986; 67():145-6. PubMed ID: 3092060
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone.
    Sell SL; McMahon LR; France CP
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1167-73. PubMed ID: 12766254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of continuous treatment with increasing doses of medazepam on a program of light discrimination].
    Provenzano PM; Gianguzza S; Coppola A
    Arch Sci Biol (Bologna); 1973; 57(1-2):57-63. PubMed ID: 4154734
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure.
    Preston KL; Bigelow GE
    J Pharmacol Exp Ther; 1994 Oct; 271(1):48-60. PubMed ID: 7525929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug discrimination in human post-addicts: agonist/antagonist opioids.
    Preston K; Bigelow G; Bickel W; Liebson I
    NIDA Res Monogr; 1988; 81():209-15. PubMed ID: 2457160
    [No Abstract]   [Full Text] [Related]  

  • 15. Analgesic effects of butorphanol in horses: dose-response studies.
    Kalpravidh M; Lumb WV; Wright M; Heath RB
    Am J Vet Res; 1984 Feb; 45(2):211-6. PubMed ID: 6711944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-administration associations and withdrawal symptoms: morphine-elicited morphine withdrawal.
    McDonald RV; Siegel S
    Exp Clin Psychopharmacol; 2004 Feb; 12(1):3-11. PubMed ID: 14769091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Operant behavior in the morphine-dependent rhesus monkey.
    Holtzman SG; Villarreal JE
    J Pharmacol Exp Ther; 1973 Mar; 184(3):528-41. PubMed ID: 4631467
    [No Abstract]   [Full Text] [Related]  

  • 18. XXII. Patterns of intravenous self-injection by morphine-addicted rats.
    Weeks JR; Collins RJ
    Res Publ Assoc Res Nerv Ment Dis; 1968; 46():288-98. PubMed ID: 5749390
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress report from the Division of Behavioral Biology, the Johns Hopkins University School of Medicine.
    Griffiths RR; Brady JV; Ator NA; Lamb R; Bigelow GE; Roache JD
    NIDA Res Monogr; 1986; 67():93-7. PubMed ID: 3092102
    [No Abstract]   [Full Text] [Related]  

  • 20. Properties of pentazocine as a discriminative stimulus in the squirrel monkey.
    White JM; Holtzman SG
    J Pharmacol Exp Ther; 1982 Nov; 223(2):396-401. PubMed ID: 7131294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.